NUVA logo

NuVasive (NUVA) EBITDA

Annual EBITDA

$216.78 M
+$104.58 M+93.21%

31 December 2022

NUVA EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

$51.41 M
+$13.39 M+35.21%

30 June 2023

NUVA Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

$201.06 M
+$11.28 M+5.94%

30 June 2023

NUVA TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NUVA EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years+32.3%+182.9%+24.7%
5 y5 years+22.9%-13.0%-15.0%

NUVA EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-14.9%-39.7%-21.8%

NuVasive EBITDA History

DateAnnualQuarterlyTTM
June 2023
-
$51.41 M(+35.2%)
$201.06 M(+5.9%)
Mar 2023
-
$38.02 M(-48.0%)
$189.78 M(-12.5%)
Dec 2022
$216.78 M(+93.2%)
$73.17 M(+90.3%)
$216.78 M(+42.8%)
Sept 2022
-
$38.45 M(-4.2%)
$151.75 M(+15.4%)
June 2022
-
$40.14 M(-38.3%)
$131.48 M(-6.7%)
Mar 2022
-
$65.02 M(+698.2%)
$140.89 M(+25.6%)
Dec 2021
$112.20 M(-31.5%)
$8.15 M(-55.2%)
$112.20 M(-30.4%)
Sept 2021
-
$18.17 M(-63.3%)
$161.26 M(-22.0%)
June 2021
-
$49.55 M(+36.4%)
$206.62 M(+43.9%)
Mar 2021
-
$36.33 M(-36.5%)
$143.58 M(-12.4%)
Dec 2020
$163.86 M(-35.6%)
$57.21 M(-10.0%)
$163.86 M(-10.9%)
Sept 2020
-
$63.53 M(-570.8%)
$183.85 M(+2.5%)
June 2020
-
-$13.49 M(-123.8%)
$179.39 M(-30.2%)
Mar 2020
-
$56.61 M(-26.7%)
$256.98 M(+0.9%)
Dec 2019
$254.63 M(+44.4%)
$77.20 M(+30.7%)
$254.63 M(+7.7%)
Sept 2019
-
$59.07 M(-7.8%)
$236.52 M(+1.9%)
June 2019
-
$64.09 M(+18.1%)
$232.05 M(+2.5%)
Mar 2019
-
$54.27 M(-8.2%)
$226.32 M(+28.3%)
Dec 2018
$176.34 M(-23.8%)
$59.09 M(+8.2%)
$176.34 M(-0.8%)
Sept 2018
-
$54.60 M(-6.4%)
$177.84 M(-3.3%)
June 2018
-
$58.36 M(+1257.5%)
$183.87 M(+0.3%)
Mar 2018
-
$4.30 M(-92.9%)
$183.28 M(-20.8%)
Dec 2017
$231.56 M(+11.3%)
$60.59 M(-0.1%)
$231.56 M(+1.4%)
Sept 2017
-
$60.62 M(+4.9%)
$228.39 M(+5.4%)
June 2017
-
$57.77 M(+9.9%)
$216.65 M(-11.3%)
Mar 2017
-
$52.58 M(-8.4%)
$244.20 M(+17.4%)
Dec 2016
$208.01 M(+0.5%)
$57.42 M(+17.5%)
$208.01 M(+5.4%)
Sept 2016
-
$48.88 M(-42.7%)
$197.41 M(+1.9%)
June 2016
-
$85.32 M(+420.5%)
$193.76 M(+28.4%)
Mar 2016
-
$16.39 M(-65.0%)
$150.94 M(-27.1%)
Dec 2015
$207.01 M(+150.8%)
$46.81 M(+3.5%)
$207.01 M(+1.3%)
Sept 2015
-
$45.24 M(+6.4%)
$204.26 M(+8.3%)
June 2015
-
$42.51 M(-41.3%)
$188.57 M(+13.3%)
Mar 2015
-
$72.46 M(+64.4%)
$166.40 M(+101.6%)
Dec 2014
$82.54 M(-17.5%)
$44.06 M(+49.1%)
$82.54 M(+16.8%)
Sept 2014
-
$29.54 M(+45.3%)
$70.67 M(-1.7%)
June 2014
-
$20.33 M(-278.3%)
$71.93 M(+7.0%)
Mar 2014
-
-$11.40 M(-135.4%)
$67.21 M(-32.8%)
Dec 2013
$100.05 M(+10.1%)
$32.20 M(+4.5%)
$100.05 M(+15.2%)
Sept 2013
-
$30.80 M(+97.3%)
$86.83 M(+5.8%)
June 2013
-
$15.61 M(-27.2%)
$82.04 M(-11.2%)
Mar 2013
-
$21.45 M(+13.0%)
$92.34 M(+1.6%)
DateAnnualQuarterlyTTM
Dec 2012
$90.88 M(-298.0%)
$18.97 M(-27.1%)
$90.88 M(+23.5%)
Sept 2012
-
$26.01 M(+0.4%)
$73.59 M(-323.8%)
June 2012
-
$25.91 M(+29.7%)
-$32.89 M(-15.6%)
Mar 2012
-
$19.98 M(+1080.7%)
-$38.98 M(-15.1%)
Dec 2011
-$45.89 M(-166.2%)
$1.69 M(-102.1%)
-$45.89 M(+69.5%)
Sept 2011
-
-$80.47 M(-506.0%)
-$27.07 M(-136.8%)
June 2011
-
$19.82 M(+51.6%)
$73.48 M(+3.4%)
Mar 2011
-
$13.07 M(-36.3%)
$71.05 M(+2.5%)
Dec 2010
$69.32 M(+60.7%)
$20.52 M(+2.2%)
$69.32 M(+13.2%)
Sept 2010
-
$20.07 M(+15.4%)
$61.22 M(+7.7%)
June 2010
-
$17.39 M(+53.3%)
$56.82 M(+10.0%)
Mar 2010
-
$11.34 M(-8.6%)
$51.65 M(+19.8%)
Dec 2009
$43.13 M(+3656.6%)
$12.41 M(-20.8%)
$43.13 M(+57.9%)
Sept 2009
-
$15.67 M(+28.2%)
$27.31 M(+116.3%)
June 2009
-
$12.22 M(+332.8%)
$12.63 M(+194.1%)
Mar 2009
-
$2.82 M(-182.9%)
$4.29 M(+274.0%)
Dec 2008
$1.15 M(-126.7%)
-$3.41 M(-444.5%)
$1.15 M(-79.3%)
Sept 2008
-
$989.00 K(-74.6%)
$5.54 M(+19.1%)
June 2008
-
$3.89 M(-1310.9%)
$4.66 M(-489.3%)
Mar 2008
-
-$321.00 K(-132.5%)
-$1.20 M(-72.2%)
Dec 2007
-$4.30 M(-83.3%)
$989.00 K(+879.2%)
-$4.30 M(-39.8%)
Sept 2007
-
$101.00 K(-105.1%)
-$7.15 M(-54.4%)
June 2007
-
-$1.97 M(-42.6%)
-$15.68 M(-51.1%)
Mar 2007
-
-$3.42 M(+84.3%)
-$32.09 M(-11.5%)
Dec 2006
-$25.76 M(+80.9%)
-$1.86 M(-78.0%)
-$36.26 M(-2.2%)
Sept 2006
-
-$8.44 M(-54.1%)
-$37.09 M(+11.0%)
June 2006
-
-$18.37 M(+142.0%)
-$33.41 M(+79.5%)
Mar 2006
-
-$7.59 M(+182.7%)
-$18.62 M(+30.8%)
Dec 2005
-$14.24 M(+15.4%)
-$2.69 M(-43.5%)
-$14.24 M(+2.8%)
Sept 2005
-
-$4.76 M(+32.8%)
-$13.85 M(+18.5%)
June 2005
-
-$3.58 M(+11.4%)
-$11.69 M(-2.4%)
Mar 2005
-
-$3.21 M(+39.8%)
-$11.97 M(-2.9%)
Dec 2004
-$12.33 M(+50.6%)
-$2.30 M(-11.3%)
-$12.33 M(+22.9%)
Sept 2004
-
-$2.59 M(-32.9%)
-$10.03 M(+34.9%)
June 2004
-
-$3.87 M(+8.2%)
-$7.44 M(+603.2%)
Mar 2004
-
-$3.57 M(-242.1%)
-$1.06 M(-127.5%)
Dec 2003
-$8.19 M(-39.0%)
-
-
June 2003
-
$2.52 M(+89.7%)
$3.84 M(+189.7%)
Mar 2003
-
$1.33 M
$1.33 M
Dec 2002
-$13.42 M(+119.3%)
-
-
Dec 2001
-$6.12 M(-57.1%)
-
-
Dec 2000
-$14.27 M
-
-

FAQ

  • What is NuVasive annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for NuVasive?
  • What is NuVasive quarterly earnings before interest, taxes, depreciation & amortization?
  • What is the all time high quarterly EBITDA for NuVasive?
  • What is NuVasive TTM earnings before interest, taxes, depreciation & amortization?
  • What is the all time high TTM EBITDA for NuVasive?

What is NuVasive annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of NUVA is $216.78 M

What is the all time high annual EBITDA for NuVasive?

NuVasive all-time high annual earnings before interest, taxes, depreciation & amortization is $254.63 M

What is NuVasive quarterly earnings before interest, taxes, depreciation & amortization?

The current quarterly EBITDA of NUVA is $51.41 M

What is the all time high quarterly EBITDA for NuVasive?

NuVasive all-time high quarterly earnings before interest, taxes, depreciation & amortization is $85.32 M

What is NuVasive TTM earnings before interest, taxes, depreciation & amortization?

The current TTM EBITDA of NUVA is $201.06 M

What is the all time high TTM EBITDA for NuVasive?

NuVasive all-time high TTM earnings before interest, taxes, depreciation & amortization is $256.98 M